FRANCISCO JAVIER ARAGON CORRALES-ASI MI ANTOJO
⚠️ Moderate Risk
FEI: 3013004833 • Tijuana, Baja California • MEXICO
FEI Number
3013004833
Location
Tijuana, Baja California
Country
MEXICOAddress
Avenida Rio Yaqui 608d, Col. Revolucion, Tijuana, Tijuana, Baja California, Mexico
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
Refusal History
Frequently Asked Questions
What is FRANCISCO JAVIER ARAGON CORRALES-ASI MI ANTOJO's FDA import refusal history?
FRANCISCO JAVIER ARAGON CORRALES-ASI MI ANTOJO (FEI: 3013004833) has 1 FDA import refusal record(s) in our database, spanning from 3/22/2017 to 3/22/2017.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. FRANCISCO JAVIER ARAGON CORRALES-ASI MI ANTOJO's FEI number is 3013004833.
What types of violations has FRANCISCO JAVIER ARAGON CORRALES-ASI MI ANTOJO received?
FRANCISCO JAVIER ARAGON CORRALES-ASI MI ANTOJO has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about FRANCISCO JAVIER ARAGON CORRALES-ASI MI ANTOJO come from?
All FDA import refusal data for FRANCISCO JAVIER ARAGON CORRALES-ASI MI ANTOJO is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.